Innovation
1 patent family — focus: Human necessities; filing pace active. Cited 40 times.
| Year | Filings |
|---|---|
| 2024 | 1 |
| 2025 | 1 |
Social engagement
Social engagement: 1K social following, 1 post in the last 12 months — top 10% of its industry.
Investor mix
3 investors on record; lead investors include HTGF, xista.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |
Recent activity
22 Oct 2025
Product launch
Langerhans cell-targeted protein delivery technology